Therapeutic management of radiation-induced oral mucositis;Therapeutische Beeinflussung der radiogenen oralen Mukositis

Strahlentherapie und Onkologie

Volumn 173, Issue 4, 1997, Pages 183-192

  Dorr W ^a   Dolling Jochem I ^a   Baumann, M ^a   Herrmann, Th ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; AZELASTINE; BENZYDAMINE; CHLORHEXIDINE; ENZYME; EPIDERMAL GROWTH FACTOR; FLUCONAZOLE; FLUOCINOLONE ACETONIDE; FLUOROURACIL; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; IMMUNOGLOBULIN; INDOMETACIN; KAMILLOSAN; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; SILVER NITRATE; SUCRALFATE; TERLIPRESSIN; TOBRAMYCIN; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG;

CLINICAL TRIAL; HEAD AND NECK CANCER; HUMAN; MOUTH MUCOSA; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0030888823     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03039287     Document Type: Review

References (81)

1. Abdelaal, A. S., D. S. Barker, M. M. Fergusson: Treatment for irradiation-induced mucositis. Lancet 1 (1989), 97.
2. Allison, R. R., V. Vongtama, J. Vaughan, K. H. Shin: Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole. Cancer Invest. 13 (1995), 16-22.
3. Attal, M., F. Huguet, H. Rubie, J.-P. Charlet, D. Schlaifer, A. Huynh, G. Laurent, J. Pris: Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial. Blood 82 (1993), 732-736.
4. Baumann, M.: Impact of endogenous and exogenous factors on radiation sequelae. In: Dunst, J., R. Sauer (eds.): Late sequelae in oncology. Springer, Berlin 1995, p. 3-12.
5. Bianco, J. A., J. Nemunaitis, D. F. Andrews, M. Lilly, A. Shields, J. W. Singer: Combined therapy with pentoxifylline (PTX), ciprofloxacin (CIPRO) and prednisone (PD) reduces regimen related toxicity (RRT) and accelerates engraftment in patients undergoing bone marrow transplantation (BMT). Blood 38 (1991), 267-271.
6. Bjelkengren, G., K. F. Aronsen, N. E. Augustsson, S. Borgström, C. Lindström, G. Nylander: The radioprotective effect of locally administered glypressin on the rectal mucosa. A study in the rat. ESTRO, 6th Annual Meeting 1987. Book of Abstracts p. 287.
7. Bjornberg, A., L. Hellgren, S. Olsson: Treatment of radiation dermatitis with fluocinolone acetonide. Acta Radiol. Ther. Phys. Biol. 3 (1965), 129-134.
8. Borowski, B., E. Benhamou, J. L. Pico, A. Laplanche, J. P. Margainaud, M. Hayat: Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Europ. J. Cancer 30-B (1994), 93-97.
9. Bruce, W. R., W. R. Barklay: The suppression by cortisone on the acute local radiation reaction in the rabbit ear. Radiat. Res. 13 (1960), 168.
10. Carl, W., L. S. Emrich: Management of oral mucositis during local radiation and systemic chemotherapy: a study of 98 patients. J. prosthet. Dent. 66 (1991), 361-369.
11. Cascinu, S., A. Fedeli, S. L. Fedeli, G. Catalano: Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. Europ. J. Cancer 30-B (1994), 234-236.
12. Ciais, G., M. Namer, M. Schneider, F. Demard, N. Pourreau-Schneider, P. M. Martin, M. Soudry, J. C. Franquin, H. Zattara: Soft-laser therapy for prevention and treatment of mucositis induced cancer chemotherapy. Bull. Cancer 79 (1992), 183-191.
13. Dietz, A., J. Nollert, H. Maier, V. Rudat, M. Flentje: Zur Problematik der radiogen- bzw. chemotherapieinduzierten Mukositis der Mundschleimhaut am Beispiel der akzelerierten Radiochemotherapie mit Carboplatin bei Patienten mit inoperablen Plattenepithelkarzinomen des Kopf-/Halsbereichs. HNO 43 (1995), 403-413.
14. Dörr, W., A. Jacubek, J. Kummermehr, T. Herrmann, I. Dölling-Jochem, U. Eckelt: Effects of stimulated repopulation on oral mucositis during conventional radiotherapy. Radiother. Oncol. 37 (1995), 100-107.
15. Dörr, W., J. Kummermehr: Increased radiation tolerance of mouse tongue epithelium after local conditioning. Int. J. Radiat. Biol. 61 (1992). 369-379.
16. Epstein, J. B., P. Stevenson-Moore: Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy. Oral Surg. oral Med. oral Path. 62 (1986), 145-148.
17. Epstein, J. B., P. Stevenson-Moore, S. Jackson, J. H. Mohamed, J. J. Spinelli: Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse. Int. J. Radiat. Oncol. Biol. Phys. 16 (1989), 1571-1575.
18. Epstein, J. B., F. L. W. Wong: The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 28 (1994), 693-698.
19. Estler, C.-J.: Lehrbuch der allgemeinen und systematischen Pharmakologie und Toxikologie. Schattauer, Stuttgart-New York 1986.
20. Ferretti, G. A., T. P. Raybould, A. T. Brown, J. S. Macdonald, M. Greenwood, Y. Maruyama, J. Geil, T. T. Lillich, R. C. Ash: Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial. Oral Surg. oral Med. oral Path. 69 (1990), 331-338.
21. Fletcher, G. H.: Basic clinical parameters. In: Fletcher, G. H. (ed.): Textbook of radiotherapy, 3rd ed. Lea and Febiger, Philadelphia 1980, p. 180-224.
22. Foote, R. L., C. L. Loprinzi, A. R. Frank, J. R. O'Fallon, S. Gulavita, H. H. Tewfik, M. A. Ryan, J. M. Earle, P. Novotny: Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J. clin. Oncol. 12 (1994), 2630-2633.
23. Franzén, L., R. Henriksson, B. Littbrand, B. Zackrisson: Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. Acta Oncol. 34 (1995), 219-223.
24. Guttenberger, R., Y. Feng, N. Hunter, K. K. Ang, R. Price: Effects of TGF-α on radiation response in lip and jejunal mucosa in mice. In: Chapman, J. D., W. C. Dewey, G. F. Whitmore (eds.). Radiation research: a twentieth-century perspective. Vol. I: Congress abstracts. Academic Press Inc. San Diego-New York-Boston 1991, p. 151.
25. Hamilton, E., C. S. Potten: Influence of hair plucking on the turnover of the epidermal basal layer. Cell Tiss. Kinet. 5 (1972), 505-517.
26. Hennings, H., K. Elgjo: Epidermal regeneration after cellophane tape stripping of hairless mouse skin. Cell Tiss. Kinet. 3 (1970), 243-252.
27. Herrmann, T., A. Jacubek, K. R. Trott: The importance of the timing of a gap in radiotherapy of squamous cell carcinomas of the head and neck. Strahlenther. Onkol. 170 (1994), 545-549.
28. Hopewell, J. W., M. E. C. Robbins, G. J. M. J. Van den Aardweg, G. M. Morris, G. A. Ross, E. Whitehouse, D. F. Horrobin, C. A. Scott: The modulation of radiation-induced damage to pig skin by essential fatty acids. Brit. J. Cancer 68 (1993), 1-7.
29. Hopewell, J. W., G. J. M. J. Van den Aardweg, G. M. Morris, M. Rezvani, M. E. C. Robbins, G. Ross, E. M. Whitehouse, C. A. Scott, D. F. Horrobin: Amelioration of both early and late radiation-induced damage to pig skin by essential fatty acids. Int. J. Radiat. Oncol. Biol. Phys. 30 (1994), 1119-1125.
30. Houghton, L. E., J. B. Walter, D. E. A. Jones: The inhibition of acute X-ray damage by cortisone. Brit. med. J. (1954), 1313.
31. Janjan, N. A., D. E. Weissman, A. Pahule: Improved pain management with daily nursing intervention during radiation therapy for head and neck carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 23 (1992), 647-752.
32. Kaanders, J. H. A. M., L. A. M. Pop, H. L. Muytjens, I. Bruaset, W. A. J. Van Daal: Topical administration of antimicrobial agents to prevent irradiation mucositis of the oral cavity and oropharynx: a pilot study. Radiat. Oncol. Invest. 2 (1996), 283-290.
33. Kalz, F., A. Scott: Inhibition of grenz ray erythema by one single topical hormone application. J. Invest Derm. 26 (1956), 165-172.
34. Kim, J. H., F. C. H. Chu, V. Lakshmi, R. Houde: Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx. Amer. J. clin. Oncol. 9 (1986), 132-134.
35. Konturek, S. J., J. W. Konturek, T. Brzozowski, B. L. Slomiany, A. Slomiany: Effects of sucralfate on growth factor availability. In: Hollander, T., G. N. J. Tygtat (eds.): Sucralfate. From basic science to bedside. Plenum Med. Book Co., New York-London 1995, p. 175-189.
36. Kuhrer, I., R. Kuzmits, W. Linkesch, H. Ludwig: Topical PGE2 enhances healing of chemotherapy-associated mucosal lesions. Lancet 1 (1986), 623.
37. Kuwayama, H.: Sucralfate and cell proliferation. In: Hollander, T., G. N. J. Tygtat (eds.): Sucralfate. From basic science to the bedside. Plenum Med. Book Co., New York-London 1995, p. 141-149.
38. Labar, B., M. Mrsic, Z. Pavletic, V. Bogdanic, D. Nemet, I. Aurer, I. Radmann, N. Filipovic-Grcic, D. Sertic, S. Kalenic, P. Presecki: Prostaglandin E2 for prophylaxis of oral mucositis following BMT. Bone Marrow Transpl. 11 (1993), 379-382.
39. Lisciana, R., P. Scorza-Barcellona, B. Silvestrini: Research on the topical activity of Benzydamine. Europ. J. Pharmacol. 3 (1968), 57-162.
40. Maciejewski, B., H. R. Withers, J. M. G. Taylor, A. Hliniak: Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Pan 2: Normal tissue responses: acute and late effects. Int. J. Radiat. Oncol. Biol. Phys. 18 (1990), 101-111.
41. Maciejewski, B., A. Zajusz, B. Pilecki, K. Swiatnicka, W. Dörr, J. Kummermehr, K.-R. Trott: Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer. Radiother. Oncol. 22 (1991), 7-11.
42. Mahood, D. J., A. M. Dose, C. L. Loprinzi, M. H. Veeder, L. M. Athmann, T. M. Therneau, J. M. Sorensen, D. K. Gainey, J. A. Mailliard, N. L. Gusa, G. K. Finck, C. Johnson, R. M. Goldberg: Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J. clin. Oncol. 9 (1991), 449-452.
43. Mealey, B. L., S. E. Semba, W. W. Hallmon: The head and neck radiotherapy patient. Part 2: Management of oral complications. Compend. Contin. Educ. Dent. 15 (1994), 442-452.
44. Morales, P. L.: The effect of ACTH and cortisone on the erythema reaction to low kilovoltage radiation. Amer. J. Roentgenol. 70 (1953), 1015.
45. Mose, S., I. A. Adamietz, F. Saran, C. Thilmann, R. Heyd, H. D. Böttcher: Wirksamkeit der prophylaktischen Anwendung von Immunglobulin bei der radiogenen Mukositis. Strahlenther. Onkol. 171 (1995), 415-416.
46. Mose, S., I. A. Adamietz, C. Thilmann, F. Saran, R. Heyd, R. Knecht, H. D. Böttcher: Immunglobulin zur Prophylaxe der radiogen induzierten Mukositis. HNO 43 (1995), 421-426.
47. Nicopoulos, N., A. Mantidis, E. Stathopoulos, S. Papaodysseas, J. Kouvaris, H. Varveris, C. Papavasiliou: Prophylactic administration of indomethacin for irradiation esophagitis. Radiother. Oncol. 3 (1985), 23-25.
48. Ohlsén, L., H. Evers, K. Segerstrom, E. Hagelqvist, S. Graffman: Local anaesthetics modifying the dermal response of radiation. Acta Oncol. 26 (1987), 467-476.
49. Osaki, T., E. Ueta, K. Yoneda, J. Hirota, T. Yamamoto: Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by azelastine hydrochloride (azelastine) with other antioxidants. Head Neck 16 (1994), 331-339.
50. Overgaard, J., M. Hjelm-Hansen, L. Vendelbo Johansen, A. P. Andersen: Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol. 27 (1988), 147-152.
51. Pfeiffer, P., E. L. Madsen, O. Hansen, O. May: Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy. Acta Oncol. 29 (1990), 171-173.
52. Pillsbury, H. C., W. P. Webster, J. G. Rosenman: Prostaglandin inhibitor and radiotherapy in advanced head and neck cancers. Arch. Otolaryng. Head Neck Surg. 112 (1986), 552-553.
53. Porteder, H., E. Rausch, G. Kment, G. Watzek, M. Matejka, H. Sinzinger: Local prostaglandin E2 in patients with oral malignancies undergoing chemo- and radiotherapy. J. cranio-maxillofac. Surg. 16 (1988), 371-374.
54. Potten, C. S., C. A. Chadwick: Small intestinal growth regulatory factors extracted by simple diffusion from intact irradiated intestine and tested in vivo. Growth Factors 10 (1994), 63-75.
55. Potten, C. S., G. Owen, D. Hewitt, C. A. Chadwick, H. Hendry, B. I. Lord, L. B. Woolford: Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors. Gut 36 (1995), 864-873.
56. Prada, A., F. Chiesa: Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy. Int. J. Tiss. React. 9 (1987), 115-119.
57. Puorreau-Schneider, N., M. Soudry, J. C. Franquin, H. Zattara, P. M. Martin, G. Ciais, M. Namer, M. Schneider, P. Chauvel, F. Demard: Soft laser therapy for iatrogenic mucositis in cancer patients receiving high-dose fluorouracil: a preliminary report. J. nat. Cancer Inst. 84 (1992), 358-359.
58. Rachmilewitz, D.: Stimulation of mucosal prostaglandins by sucralfate. In: Hollander, T., G. N. J. Tygtat (eds.): Sucralfate. From basic science to the bedside. Plenum Med. Book Co., New York-London 1995, p. 127-132.
59. Rocke, L. K., C. L. Loprinzi, J. K. Lee, S. J. Kunselman, R. K. Iverson, G. Finck, D. Lifsey, K. C. Glaw, B. A. Stevens, A. K. Hatfield, N. L. Vaught, J. Bartel, N. Pierson: A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer 72 (1993), 2234-2238.
60. Rugg, T., M. I. Saunders, S. Dische: Smoking and mucosal reactions to radiotherapy. Brit. J. Radiol. 63 (1990), 554-556.
61. Rutkauskas, J. S., J. W. Davis: Effects of chlorhexidine during immunosuppressive chemotherapy. Oral Surg. oral Med. oral Path. 76 (1993), 441-448.
62. Samaranayake, L. P., A. G. Robertson, T. W. MacFarlane, I. P. Hunter, G. MacFarlane, D. S. Soutar, M. M. Ferguson: The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin. Radiol. 39 (1988), 291-294.
63. Schedler, M., H. Feidt, M. Niewaldt: Läßt sich die radiogene Mukositis mit Immunglobulin behandeln? Zbl. Hals-Ohren-Heilk. Kopf-Hals-Chir. 139 (1990), 3-4.
64. Scherlacher, A., F. Beaufort-Spontin: Strahlentherapie von Kopf-Hals-Malignomen: Entzündungsprophylaxe der Schleimhaut durch Sucralfatbehandlung. HNO 38 (1990), 24-28.
65. Shenep, J., D. K. Kalwinsky, P. R. Hutson, S. L. George, R. K. Dodge, K. R. Blankenship, D. Thornton: Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis. J. Pediat. 113 (1988), 768-793.
66. Sonis, S. T., C. Lindqvist, A. Van Vugt, A. A. Stewart, K. Stam, G.-Y. Qu, K. K. Iwata, J. O. Haley: Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor β3. Cancer Res. 54 (1994), 1135-1138.
67. Steeb, C. B., J. F. Trahair, L. C. Read: Administration of insulin-like growth factor-I (IGF-I) peptides for three days stimulates proliferation of the small intestinal epithelium in rats. Gut 37 (1995), 630-638.
68. Stockschläder, M., P. Kalhs, S. Peters, W. Zeller, W. Krüger, H. Kabisch, K. Lechner, A. Zander: Intravenous pentoxifylline failed to prevent transplant-related toxicities in allogeneic bone narrow transplant recipients. Bone Marrow Transplant. 12 (1993), 357-362.
69. Stricter, R. M., P. A. Remick, R. N. Ward, R. N. Spengler, J. P. Lynch, J. Larrick, S. L. Kunkel: Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem. biophys. Res. Comm. 155 (1988), 1230.
70. Sur, R. K., R. Kochbar, D. P. Singh: Oral sucralfate in acute radiation oesophagitis. Acta Oncol. 33 (1994), 61-63.
71. Sweet, R. D.: Acute accidential superficial X-ray burns. Brit. J. Dermat. 74 (1962), 392-398.
72. Tochner, Z., M. Barnes, J. B. Mitchell, K. Orr, E. Glatstein: Protection by indomethacin against acute radiation esophagitis. Digestion 47 (1990), 81-87.
73. Trott, K.-R., J. Kummermehr: What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation. Radiother. Oncol. 3 (1985), 1-9.
74. Van der Jagt, R. H. C. G. Pari, S. A. McDiarmid, D. M. Boisvert, L. B. Huebsch: Effect of pentoxifylline on regimen related toxicity in patients undergoing allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant. 13 (1994), 203-207.
75. Van der Schueren, E., W. Van den Bogaert, L. Vanuytsel, E. Van Limbergen: Radiotherapy by multiple fractions per day (MFD) in head and neck cancer acute reactions of skin and mucosa. Int. J. Radiat. Oncol. Biol. Phys. 19 (1990), 301-311.
76. Verdi, C. J.: Cancer therapy and oral mucositis. An appraisal of drug prophylaxis. Drug Safety 9 (1993), 185-195.
77. Vinzenz, K., U. Stauder: Die Therapie der radiogenen Mukositis mit Enzymen. In: Vinzenz, K., H. W. Waclawiczek (eds.): Chirurgische Therapie von Kopf-Hals-Karzinomen. Springer, Wien 1992, p. 299-314.
78. Wang, R., A. Boyle: A convenient method for guarding against localized mucositis during radiation therapy. J. Prosth. 3 (1994), 198-201.
79. Weinberg, J. B., S. N. Mason, T. S. Wortham: Inhibition of tumor necrosis factor-a (TNF-α) and interleukin (IL-1β) messenger-RNA (or RNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: dissociation of acivicin-induced TNF-α and IL-1β-mRNA expression from acivicin-induced monocyloid differentiation. Blood 79 (1992), 3337-3343.
80. Weisdorf, D. J., B. Bostrom, D. Raether, M. Mattingly, P. Walker, B. Pihlstrom, P. Ferrieri, R. Haake, A. Goldman, W. Woods: Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. Bone Marrow Transplant 4 (1989), 89-95.
81. Zaghloul, M. S., M. J. Done, R. F. Kallman: Interleukin 1β protects against the acute reaction of the mouse lip inflicted by irradiation and irradiation combined with cyclophosphamide (CY). Radiation research Society, 40th Annual Meeting, Book of Abstracts 1992, p. 18.